These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 12396608)
61. Progress in vaccine development against SIV and HIV. Bolognesi DP J Acquir Immune Defic Syndr (1988); 1990; 3(4):390-4. PubMed ID: 1690288 [No Abstract] [Full Text] [Related]
62. Anti-HIV vaccines. Current status and future developments. Norley SG; Vogel T; Kurth R Drugs; 1993 Dec; 46(6):947-60. PubMed ID: 7510612 [No Abstract] [Full Text] [Related]
63. Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies. O'Connor DH; Allen TM; Watkins DI DNA Cell Biol; 2002 Sep; 21(9):659-64. PubMed ID: 12396608 [TBL] [Abstract][Full Text] [Related]
64. Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection. O'Connor D; Friedrich T; Hughes A; Allen TM; Watkins D Immunol Rev; 2001 Oct; 183():115-26. PubMed ID: 11782252 [TBL] [Abstract][Full Text] [Related]
65. New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview. Girard M; Habel A; Chanel C C R Acad Sci III; 1999 Nov; 322(11):959-66. PubMed ID: 10646090 [TBL] [Abstract][Full Text] [Related]
66. Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes. Peyerl FW; Barouch DH; Letvin NL Viral Immunol; 2004; 17(2):144-51. PubMed ID: 15279695 [TBL] [Abstract][Full Text] [Related]
67. Macaque models for AIDS vaccine development. Johnson RP Curr Opin Immunol; 1996 Aug; 8(4):554-60. PubMed ID: 8794019 [TBL] [Abstract][Full Text] [Related]
68. Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies. Daniel MD; Desrosiers RC AIDS; 1989; 3 Suppl 1():S131-3. PubMed ID: 2558686 [No Abstract] [Full Text] [Related]